2024
Immunotherapy utilization in stage IIIA melanoma: less may be more
Frey A, Kerekes D, Khan S, Tran T, Kluger H, Clune J, Ariyan S, Sznol M, Ishizuka J, Olino K. Immunotherapy utilization in stage IIIA melanoma: less may be more. Frontiers In Oncology 2024, 14: 1336441. PMID: 38380358, PMCID: PMC10876869, DOI: 10.3389/fonc.2024.1336441.Peer-Reviewed Original ResearchStage IIIA melanomaHigh-volume centersRisk-adjusted survivalLow-volume centersImmunotherapy utilizationAdjuvant immunotherapyStage IIIATreatment of stage III melanomaAcademic centersMultivariable Cox proportional hazards regressionStage III melanomaNational Cancer DatabaseStage III diseaseFactors associated with receiptCox proportional hazards regressionCompare patient outcomesProportional hazards regressionIII melanomaImmunotherapy receiptReceiving immunotherapyIII diseaseImmunotherapy agentsOverall survivalSurvival benefitAdjuvant treatment
2019
Comparison on Clinicopathological Features, Treatments and Prognosis between Proximal Gastric Cancer and Distal Gastric Cancer: A National Cancer Data Base Analysis
Wang X, Liu F, Li Y, Tang S, Zhang Y, Chen Y, Khan SA. Comparison on Clinicopathological Features, Treatments and Prognosis between Proximal Gastric Cancer and Distal Gastric Cancer: A National Cancer Data Base Analysis. Journal Of Cancer 2019, 10: 3145-3153. PMID: 31289585, PMCID: PMC6603385, DOI: 10.7150/jca.30371.Peer-Reviewed Original ResearchProximal gastric cancerDistal gastric cancerNeoadjuvant therapyAdjuvant therapyGastric cancerClinicopathological featuresGastric adenocarcinomaNational Cancer Data Base analysisAdvanced stageCox proportional hazards modelNational Cancer DatabaseAdvanced tumor stageDistant metastasis stageOptimal therapeutic strategyProportional hazards modelAdvanced diseaseSurvival benefitClinicopathologic characteristicsPGC patientsWorse prognosisKaplan-MeierTumor stageTumor locationCancer DatabaseMetastasis stage
2018
Review and current state of radiation therapy for locally advanced pancreatic adenocarcinoma
Blakaj A, Stein SM, Khan SA, Johung KL. Review and current state of radiation therapy for locally advanced pancreatic adenocarcinoma. Journal Of Gastrointestinal Oncology 2018, 9: 1027-1036. PMID: 30603121, PMCID: PMC6286948, DOI: 10.21037/jgo.2018.03.07.Peer-Reviewed Original ResearchStereotactic body radiation therapyManagement of LAPCRadiation therapyPancreatic cancerGood treatment tolerabilityProgressive local diseaseAdvanced pancreatic adenocarcinomaAdvanced pancreatic cancerEffective systemic therapyOverall poor prognosisBody radiation therapyTime of deathAreas of controversyTreatment tolerabilityLocal progressionSystemic regimensSurvival benefitSystemic therapyDose escalationImmune therapySignificant morbidityLocal diseasePoor prognosisOptimal treatmentPancreatic adenocarcinoma